Unknown NA INTERVENTIONAL 2-arm NCT02672085

In Vivo Clinical and Radiological Effects of Platelet-rich Plasma on Interstitial Supraspinatus Lesion: Randomized Study (PRP Randomized)

Sponsor: La Tour Hospital

Conditions Platelet-rich Plasma (PRP) Supraspinatis Interstitial Partial-thickness Tears

Updated 6 times since 2017 Last updated: Aug 18, 2017 Started: Jun 30, 2015 Primary completion: Oct 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Platelet-rich Plasma (PRP) and Supraspinatis Interstitial Partial-thickness Tears and is currently ongoing. La Tour Hospital leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

La Tour Hospital
Rive Droite SA

Data source: La Tour Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Meyrin, Switzerland